COMPANY PROFILE
| Price and Volume | |
|---|---|
| Recent Price | 22.89 |
| 52 Week High | 26.14 |
| 52 Week Low | 15.75 |
| Avg. Daily Vol. (Mil) | 1.41 |
| Beta (3 year) | 0.48 |
| Share Related Items | |
| Mkt Cap (Mil) | 2,684.06 |
| Shares Out (Mil) | 117.26 |
| Float (Mil) | 116.65 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 1.30 |
| Current Ratio | 1.90 |
| LT Debt/ Equity | 0.24 |
| Total Debt / Equity | 0.24 |
| Valuation Ratios | |
| Price Earnings | 13.90 |
| Price/Sales | 1.90 |
| Price/Book | 2.00 |
| Price/Cash Flow | 9.50 |
| Per Share Data | |
| Earnings | 1.65 |
| Sales | 12.04 |
| Book Value | 11.46 |
| Cash Flow | 2.40 |
| Business Summary | |
|---|---|
| A specialty pharmaceutical company, which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain. | |
| General Information | |
| 100 Endo Boulevard
Chadds Ford, PA 19317 |
|
| www.endo.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 1216 | |
| CEO: David P. Holveck | |
| Short Interest | |
| Current Month (Mil) | 6.20 |
| Previous Month (Mil) | 7.83 |
| Short Interest Ratio (Days) | 4.50 |
| Management Effectiveness | |
| Return on Equity | 14.40 |
| Return on Assets | 7.70 |
| Return on Investments | 11.60 |
| Profitability | |
| Gross Margin | 81.30 |
| EBIT Margin | 23.20 |
| Profit Margin | 13.70 |